<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Community:</title>
  <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46279" />
  <subtitle />
  <id>http://dspace.bsuedu.ru/handle/123456789/46279</id>
  <updated>2026-04-05T19:37:00Z</updated>
  <dc:date>2026-04-05T19:37:00Z</dc:date>
  <entry>
    <title>Study of analgesic activity and effects of new dipharmacophores - nebracetam and cyclooxygenase-2 inhibitors derivatives on the cognitive abilities of rats</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46665" />
    <author>
      <name>Slyusarenko, V. S.</name>
    </author>
    <author>
      <name>Kovalenko, S. M.</name>
    </author>
    <author>
      <name>Chuev, V. P.</name>
    </author>
    <author>
      <name>Gureev, V. V.</name>
    </author>
    <author>
      <name>Korokin, M. V.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/46665</id>
    <updated>2022-05-12T00:08:33Z</updated>
    <published>2021-01-01T00:00:00Z</published>
    <summary type="text">Title: Study of analgesic activity and effects of new dipharmacophores - nebracetam and cyclooxygenase-2 inhibitors derivatives on the cognitive abilities of rats
Authors: Slyusarenko, V. S.; Kovalenko, S. M.; Chuev, V. P.; Gureev, V. V.; Korokin, M. V.
Abstract: The aim of the present study was to research the analgesic activity and effect of new dipharmacophore compounds consisting of substances with proven therapeutic activity, namely nebracetam-ibuprofen (NRIP), nebracetam-dexibuprofen (NRDIP), nebracetam-niflumic acid (NRNFA), and nebracetam-mefenamic acid (NRMFA), on the cognitive abilities of rats</summary>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Optimization of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances with Amiodarone-associated thyrotoxicosis</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46664" />
    <author>
      <name>Safronenko, A. V.</name>
    </author>
    <author>
      <name>Lepyavka, S. V.</name>
    </author>
    <author>
      <name>Demidov, I. A.</name>
    </author>
    <author>
      <name>Nazheva, M. I.</name>
    </author>
    <author>
      <name>Maklyakov, Y. S.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/46664</id>
    <updated>2022-05-12T00:05:19Z</updated>
    <published>2021-01-01T00:00:00Z</published>
    <summary type="text">Title: Optimization of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances with Amiodarone-associated thyrotoxicosis
Authors: Safronenko, A. V.; Lepyavka, S. V.; Demidov, I. A.; Nazheva, M. I.; Maklyakov, Y. S.
Abstract: The effectiveness of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances against the background of Amiodarone-associated thyrotoxicosis, high anxiety and cyclothymiae disorders should be based on the pharmacological positions of the need to reduce the risk of dangerous adverse cardiovascular reactions</summary>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>"The obesity paradox" in patients with atrial fibrillation according to the results of the REKUR-AF study</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46663" />
    <author>
      <name>Polshakova, I. L.</name>
    </author>
    <author>
      <name>Povetkin, S. V.</name>
    </author>
    <author>
      <name>Gaponov, A. Y.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/46663</id>
    <updated>2022-05-12T00:12:15Z</updated>
    <published>2021-01-01T00:00:00Z</published>
    <summary type="text">Title: "The obesity paradox" in patients with atrial fibrillation according to the results of the REKUR-AF study
Authors: Polshakova, I. L.; Povetkin, S. V.; Gaponov, A. Y.
Abstract: To evaluate the effect of excess body weight (EBW) and obesity on the survival of patients with atrial fibrillation (AF) in the REKUR-AF study</summary>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Modern approaches to pharmacotherapy of tuberculosis infection in children</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46662" />
    <author>
      <name>Novikov, V. E.</name>
    </author>
    <author>
      <name>Usacheva, N. E.</name>
    </author>
    <author>
      <name>Myakisheva, T. V.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/46662</id>
    <updated>2022-05-12T00:09:05Z</updated>
    <published>2021-01-01T00:00:00Z</published>
    <summary type="text">Title: Modern approaches to pharmacotherapy of tuberculosis infection in children
Authors: Novikov, V. E.; Usacheva, N. E.; Myakisheva, T. V.
Abstract: Anti-tuberculosis drugs (anti-TB drugs) are divided into 3 lines, taking into account drug sensitivity in Mycobacterium tuberculosis (MBT). First-line anti-TB drugs (basic) are used to treat TB caused by drug-susceptible MBT. Second- and third-line (reserve) drugs are recommended for the treatment of MBT-induced multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB, respectively</summary>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

